Can quantitative tests of liver function discriminate between different etiologies of liver cirrhosis?

Digestive Diseases and Sciences

Volumn 47, Issue 12, 2002, Pages 2669-2673

  Herold, Christoph ^a,b   Regn, Sabine ^a   Ganslmayer, Marion ^a   Ocker, Matthias ^a   Hahn, Eckhart G ^a   Schuppan, Detlef ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Liver cirrhosis; Quantitative testing of liver function

Indexed keywords

AMINOPHENAZONE; GALACTOSE; INDOCYANINE GREEN; SORBITOL;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BREATH ANALYSIS; CORRELATION ANALYSIS; FEMALE; HUMAN; INFLAMMATORY DISEASE; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; VIRUS HEPATITIS;

AGED; BREATH TESTS; FEMALE; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER CIRRHOSIS, BILIARY; LIVER FUNCTION TESTS; MALE; MIDDLE AGED;

EID: 0036912743     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021088618300     Document Type: Article

References (33)

1. Stremmel W, Wojdat R, Groteguth R, Zoedler M, Ebener T, Niederau C, Becker H, Strohmeyer G: Liver function tests in a clinical comparison. Z Gastroenterol 30:784-790, 1992
2. Herold C, Berg P, Kupfal D, Becker D, Schuppan D, Hahn EG, Schneider HT: Parameters of microsomal and cytosolic liver function but not of liver perfusion predict portal vein velocity in noncirrhotic patients with chronic hepatitis C. Dig Dis Sci 45:2233-2237, 2000
3. Herold C, Heinz R, Radespiel-Troger M, Schneider HT, Schuppan D, Hahn EG: Quantitative testing of liver function in patients with cirrhosis due to chronic hepatitis C to assess disease severity. Liver 21:26-30, 2001
4. Hemming AW, Scudamore CH, Shackleton CR, Pudek M, Erb SR: Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg 163:515-518, 1992
5. Nonami T, Nakao A, Kurokawa T, Inagaki H, Matsushita Y, Sakamoto J, Takagi H: Blood loss and ICG clearance as best prognostic markers of post-hepatectomy liver failure. Hepatogastroenterology 46:1669-1672, 1999
6. Plevris JN, Jalan R, Bzeizi KI, Dollinger MM, Lee A, Garden OJ, Hayes PC: Indocyanine green clearance reflects reperfusion injury following liver transplantation and is an early predictor of graft function. J Hepatol 30:142-148, 1999
7. Ranek L, Andreasen PB, Tygstrup N: Galactose elimination capacity as a prognostic index in patients with fulminant liver failure. Gut 17:959-964, 1976
8. 14C aminopyrine breath test. Br Med J 280:279-280, 1980
9. Herold C, Heinz R, Niedobitek G, Schneider HT, Hahn EG, Schuppan D: Quantitative testing of liver function in relation to fibrosis in patients with chronic hepatitis B and C. Liver 2001 (in press)
10. Ludwig J. The nomenclature of chronic active hepatitis: An obituary. Gastroenterology 105:274-278, 1993
11. Turcotte JG, Child CG: Surgery and portal hypertension. Major Probl Clin Surg 1:1-85, 1964
12. 14C-aminopyrine. Digestion 39:241-250, 1988
13. Tygstrup N, Andersen P, Thompsen BL: Prognostic evaluation in alcoholic cirrhosis. Acta Med Scand 703:149-153, 1986
14. Zeeh J, Lange H, Bosch J, Pohl S, Loesgen H, Eggers R, Navasa M, Chesta J, Bircher J: Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow. Gastroenterology 95:749-759, 1988
15. Leevy CM, Mendenhall CL, Lesko W: Estimation of hepatic blood flow with indocyanine green. J Clin Invest 41:1169-1179, 1962
16. 14C]Aminopyrine breath test analysis and conventional biochemical tests as predictors of survival in cirrhosis. Dig Dis Sci 30:813-818, 1985
17. Merkel C, Gatta A, Zoli M: Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis: Comparison with the Pugh score. Dig Dis Sci 36:1197-1203, 1991
18. Merkel C, Bolognesi M, Finucci GF, Angeli P, Caregaro L, Rondana M, Gatta A: Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosis. Hepatology 9:16-22, 1989
19. Merkel C, Sacerdoti D, Bolognesi M, Buonamico P, Sticca A, Amodio P, Angeli P, Micotti L, Gatta A: Effect of chronic treatment with nadolol plus isosorbide mononitrate on liver blood flow and liver metabolic activity in cirrhosis. Eur J Gastroenterol Hepatol 11:1221-1225, 1999
20. Reichen J, Widmer T, Cotting S: Accurate prediction of death by serial determination of galactose elimination capacity (GEC) in primary biliary cirrhosis. A comparison with the Mayo-Score. Hepatology 14:504-510, 1991
21. Hashimoto M, Watanabe G: Hepatic parenchymal cell volume and the indocyanine green tolerance test. J Surg Res 92:222-227, 2000
22. Molino G, Avagnina P, Ballare M, Torchio M, Niro AG, Aurucci PE, Grosso M, Fava C: Combined evaluation of total and functional liver plasma flows and intrahepatic shunting. Dig Dis Sci 36:1189-1196, 1991
23. Beuers U, Jager F, Wahllander A, Ansari H, Kirsch CM: Prognostic value of the intravenous 14C-aminopyrine breath test compared to the Child-Pugh score and serum bile acids in 84 cirrhotic patients. Digestion 50:212-218, 1991
24. Monroe PS, Baker AL, Schneider JF, Krager PS, Klein PD, Schoeller D: The aminopyrine breath test and serum bile acids reflect histologic severity in chronic hepatitis. Hepatology 2:317-322, 1982
25. Urbain D, Muls V, Makhoul E, Jeghers O, Thys O, Ham HR: Prognostic significance of hepatic venous pressure gradient in medically treated alcoholic cirrhosis: Comparison to aminopyrine breath test. Am J Gastroenterol 88:856-859, 1993
26. Wensing G, Lotterer E, Link I, Hahn EG, Fleig WE: Urinary sodium balance in patients with cirrhosis: Relationship to quantitative parameters of liver function. Hepatology 26:1149-1155, 1997
27. 14C]aminopyrine demethylation capacity after portocaval shunting. Comparative study in patients with and without arterializafion of portal vein. Dig Dis Sci 38:2177-2182, 1993
28. Lotterer E, Hogel J, Gaus W, Fleig WE, Bircher J: Quantitative liver function tests as surrogate markers for end-points in controlled clinical trials: A retrospective easibility study. Hepatology 26:1426-1433, 1997
29. v Schonfeld J, Breuer N, Zotz RB, Beste M, Goebell H: Serial quantitative liver function tests in patients with primary biliary cirrhosis: A prospective long-term study. Digestion 58:396-401, 1997
30. Cavanna A, Molino G, Ballare M. Non-invasive evaluation of portal-systemic shunting in man by D-Sorbitol bioavailability. J Hepatol 5:154-161, 1987
31. Andersen V, Sonne J, Court-Payen M, Sletting S, Prip A, Molholm Hansen J: Liver volume, portal vein flow, and clearance of indocyanine green and antipyrine in hyperthyroidism before and after antithyroid treatment. Scand J Gastroenterol 34:618-622, 1999
32. Matsui Y, Tu W, Kitade H, Nakagawa A, Kamiya T, Kwon AH, Uetsuji S, Kamiyama Y: Hepatocyte volume as an indicator of hepatic functional reserve in cirrhotic patients with liver tumours. J Gastroenterol Hepatol 11:540-545, 1996
33. Meyer-Wyss B, Renner E, Luo H, Scholer A. Assessment of lidocaine metabolite formation in comparison with other quantitative liver function tests. J Hepatol 19:133-139, 1993